Dr. Todd Arthur Fehniger, MD

Dr. Fehniger practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Fehniger's NPI, 1154447233, was assigned on March 21, 2007. Dr. Fehniger graduated from Ohio State College of Medicine in 2002. Dr. Fehniger holds Missouri license 2004030333.

Dr. Fehniger's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Fehniger also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Fehniger's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Fehniger to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fehniger practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Fehniger's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Fehniger is board certified in medical oncology by the American Board of Internal Medicine. Dr. Fehniger is licensed in Missouri.

Dmand AI lists chronic leukemia, immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Fehniger treats.

CMS data shows 607 Medicare services from Dr. Fehniger across 8 procedure codes in 2024, for 136 Medicare patients. Medicare paid $26,851 for them.

CMS counts 136 Medicare patients who saw Dr. Fehniger in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 15% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fehniger's median patient age at 71, with 43% women.

In 2024, Dr. Fehniger wrote 247 Medicare Part D claims for 28 patients. 74% of them were for generic drugs. CMS names the drug for 151 of them, across 6 drugs with 11 or more claims each, at $615,180 in total drug cost. In 2023, CMS named 109 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Fehniger for performance year 2024, reported as part of a group. Dr. Fehniger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 132 papers to Dr. Fehniger, published from 2002 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Killer Cells, Natural, Interleukin-15 and Hematopoietic Stem Cell Transplantation. Dr. Fehniger has published most often in Blood. Dr. Fehniger's most frequent co-authors are Michael A. Caligiuri, MD, John F. Dipersio, MD and Megan Anne Cooper, MD.

Dmand AI links Dr. Fehniger to 15 clinical trials, 9 of them phase 1 studies. Conditions studied include Hodgkin Disease, Multiple Myeloma and Blood Protein Disorders. Washington University School of Medicine sponsors the most, 12.

CMS Open Payments shows 2 general payments to Dr. Fehniger from 2 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 100% of the total. Pfizer Inc. paid the most, $1,500.

Dmand AI lists 1 award for Dr. Fehniger, most recently CMS Stage 1 EHR in 2012.

Dr. Fehniger graduated from Ohio State College of Medicine in 2002.

Dr. Fehniger is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.